Protecting Eyesight in a Time of Shortages: Stabilizing the Ophthalmic Pharmaceutical Supply Chain
The following article was authored by Leiters Health for our partner – EDSA: End Drug Shortage Alliance
When people think about drug shortages, the conversation often centers around hospitals and surgery centers and, rightfully so, the focus is on critical medications and life-saving therapies. But shortages don’t stop there. In ophthalmology, access to sterile, high-quality medications is just as critical, and disruptions can have life-altering consequences for patients whose vision depends on timely treatment.
Across retina practices and ophthalmology clinics, providers face increasing supply instability in both compounded and repackaged ophthalmic medications. From anti-infectives like moxifloxacin to retina therapies such as repackaged bevacizumab (Avastin®), these shortages create significant clinical challenges for physicians and staff working to save and restore their patients’ eyesight.
The post Protecting Eyesight in a Time of Shortages: Stabilizing the Ophthalmic Pharmaceutical Supply Chain appeared first on Leiters Health.